Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$249K Sell
14,217
-1,503
-10% -$29.1K ﹤0.01% 2920
2026
Q1
$331K Sell
15,720
-13,422
-46% -$303K ﹤0.01% 2544
2025
Q4
$634K Buy
29,142
+11,912
+69% +$245K ﹤0.01% 1960
2025
Q3
$322K Sell
17,230
-4,918
-22% -$106K ﹤0.01% 2225
2025
Q2
$482K Sell
22,148
-4,012
-15% -$90.5K ﹤0.01% 1880
2025
Q1
$572K Buy
+26,160
New +$605K ﹤0.01% 1683
2024
Q4
Sell
-14,204
Closed -$382K 2554
2024
Q3
$382K Buy
+14,204
New +$378K ﹤0.01% 1924
2024
Q2
Sell
-10,046
Closed -$248K 2363
2024
Q1
$248K Buy
10,046
+1,039
+12% +$24.3K ﹤0.01% 1980
2023
Q4
$211K Buy
+9,007
New +$202K ﹤0.01% 1693
2023
Q2
Sell
-5,964
Closed -$1.56M 1882
2023
Q1
$1.56M Buy
+5,964
New +$148K ﹤0.01% 801

Other funds holding PHI

Cerity Partners's PHI Position: Q2 2026 in Review

Cerity Partners reduced its PLDT (PHI) stake by 9.6% in Q2 2026, selling an estimated $29.1K and leaving 14,217 shares worth $249K. The position accounts for ﹤0.01% of the portfolio, ranked #2920.

Cerity Partners first reported a position in PHI in Q1 2023 and has held it in 10 quarters since. The position peaked at $1.56M in Q1 2023. 100 funds tracked by Wall St. Rank hold PHI as of Q2 2026.

  • Cerity Partners held 14,217 shares of PLDT worth $249K as of Q2 2026.
  • Cerity Partners sold 1,503 PLDT shares in Q2 2026, an estimated $29.1K.
  • PLDT made up ﹤0.01% of Cerity Partners's portfolio in Q2 2026, its #2920 holding.
  • Cerity Partners first reported a position in PLDT in Q1 2023 and has held it in 10 quarters since.
  • Cerity Partners's PLDT position peaked at $1.56M in Q1 2023.
  • 100 funds tracked by Wall St. Rank held PLDT as of Q2 2026.

Based on Cerity Partners's 13F filing for Q2 2026, filed 14 Aug 2026.